研究業績

2010

Papers (English)

 
Original papers


1. Atarashi R, Satoh K, Sano K, Fuse T, Yamanaka H, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamada M, Mizusawa H, Kitamoto T, McGlade A, Collins SJ, Shirabe S, Katamine S, Nishida N. Ultrasensitive human prion detection in cerebrospinal fluids using real-time quaking-induced conversion. Nat Med (In Press)

2. Furukawa Y, Hamaguchi A, Nozaki I, Iizuka T, Sasagawa T, Shima Y, Demura S, Murakami H, Kawahara N, Okuyama T, Iwasa K, Yamada M. Cervical pachymeningeal hypertrophy as the initial and cardinal manifestation of mucopolysaccaridosis type I in monozygotic twins with a novel mutation in the alpha-L-iduronidase gene. J Neurol Sci (In Press)

3. Furukawa Y, Iwasa K, Ono K, Yamada M. Fisher syndrome associated with immune thrombocytopenic purpura. Intern Med (In Press)

4. Furukawa Y, Komai K, Yamada M. Neuromyelitis optica after Japanese encephalitis vaccination. Eur J Neurol (In Press)

5. Furukawa Y, Yamaguchi W, Ito K, Hamada T, Miyaji H, Tamamura H, Yamada M. The efficacy of radiation monotherapy for Tolosa-Hunt syndrome. J Neurol 257:288-290, 2010

6. Hamaguchi A, Ishida C, Iwasa K, Abe A, Yamada M. Charcot-Marie-Tooth disease type 2D with a novel Glycyl-tRNA synthetase gene (GARS) mutation. J Neurol 257:1202-1204, 2010

7. Hirohata M, Yoshita M, Ishida C, Ikeda S, Tamaoka A, Kuzuhara S, Shoji M, Ando Y, Tokuda T, Yamada M. Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Eur J Neurol 17:823-829, 2010

8. Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation. Neurosci Lett (In Press)

9. Hudson BI, Moon YP, Kalea AZ, Khatri M, Marquez C, Schmidt AM, Paik MC, Yoshita M,
Sacco RL, DeCarli C, Wright CB, Elkind MS. Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS). Atherosclerosis (In Press)

10. Ikeda T, Noto D, Noguchi-Shinohara M, Ono K, Takahashi K, Ishida C, Yoshita M,
Kawaguchi M, Kawahara N, Iwasa K, Tomita K, Yamada M. CSF tau protein is a useful marker for effective treatment of superficial siderosis of the central nervous system: two case reports. Clin Neurol Neurosurg 112:62-64, 2010

11. Ikeda T, Ono K, Elashoff D, Condron MM, Noguchi-Shinohara M, Yoshita M, Teplow DB, Yamada M. Cerebrospinal fluid of Alzheimer’s disease patients promotes amyloid β-protein oligomerization. J Alzheimers Dis 21:81-86, 2010

12. Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle Nerve 42:140-143, 2010

13. Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Reply to the Letter by Rizzetti MC, et al. Cobalt toxiciety after total hip replacement: a neglected adverse effect. Muscle Nerve (In Press)

14. Ishida C, Komai K, Yonezawa K, Sakajiri K, Nitta E, Kawashima A, Yamada M. An autopsy case of an aged patient with spinocerebellar ataxia type 2. Neuropathology (In Press)

15. Iwasa K, Kato-Motozaki Y, Furukawa Y, Maruta T, Ishida C, Yoshikawa H, Yamada M. Up-reglation of MHC class I and class II in the skeletal muscles of myasthenia gravis. J Neuroimmunol 225:171-174, 2010

16. Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi-Shinohara M, Samuraki M, Yanase D, Yoshita M, Iwasa K, Matsunari I, Yamada M. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET, and cerebrospinal fluid biomarkers for detecting Alzheimer’s disease in a memory clinic. Dement Geriatr Cogn Disord 30:285-292, 2010

17. Morinaga A*, Hasegawa K*, Nomura R, Ookoshi T, Ozawa D, Goto Y, Yamada M, Naiki H. Critical role of interfaces and agitation on the nucleation of Aβ amyloid fibrils at low concentrations of Aβ monomers. Biochim Biophys Acta 1804:986-995, 2010 *equally contributed

18. Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M. Effects of sex hormones on Alzheimer’s disease-associated β-amyloid oligomer formation in vitro. Exp Neurol (In Press)

19. Nagoshi K, Sadakane Y, Nakamura Y, Yamada M, Mizusawa H. Illness duration of prion diseases in Japan is longer than that in other countires. J Epidemiol (In Press)

20. Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Sakai K, Yamada M. Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease. J Neurol (In Press)

21. Noto D, Takahashi K, Miyake S, Yamada M. In vitro differentiation of lineage-negative bone marrow cells into microglia-like cells. Eur J Neurosci 31:1155-1163, 2010

22. Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T,
Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M. Prospective 10-year surveillance of human prion diseases in Japan. Brain 133:3043-3057, 2010

23. Nozaki I, Tsukada T, Nakamura Y, Takanaka T, Yamada M. Multiple skull metastases from hepatocellular carcinoma successfully treated with radiotherapy. Intern Med 49:2631-2634, 2010

24. Nozaki I, Yamada M. An easy diagnostic tool distinguishing lateral medullary infarction from peripheral vertigo. Clin Neurol Neurosurg (In Press)

25. Nozaki I*, Arai M*, Takahashi K, Hamaguchi T, Yoshikawa H, Muroishi T,
Nouguchi-Shinohara M, Ito H, Itokawa M, Akiyama H, Kawata A, Yamada M. Familial ALS with G298S mutation in TARDBP : A comparison of CSF tau protein levels with those in sporadic ALS. Intern Med 49:1209-1212, 2010 *equally contributed

26. Ono K, Condron MM, Teplow DB. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity. J Biol Chem 285:23186-23197, 2010

27. Sakai K, Hamaguchi T, Yamada M. Multiple cranial nerve enhancement on MRI in primary Sjögren’s syndrome. Intern Med 49:857-859, 2010

28. Sakai K, Ono K, Ohta K, Yamada M. Progression of Cerebrovascular Lesions in Pneumococcal Meningitis. Intern Med 49:1261-1262, 2010

29. Sakai K, Ono K, Okamoto Y, Murakami H, Yamada M. Cervical flexion myelopathy in a patient showing apparent long tract signs: a severe form of Hirayama disease. Joint Bone Spine (In Press)

30. Sakai K, Yamada M. Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra. Neuropathology (In Press)

31. Sakai K, Yoshita M, Samuraki M, Yamada M. Acute disseminated encephalomyelitis with medial temporal lesions mimicking acute limbic encephalitis. Clin Neurol Neurosurg 113:72-74, 2010

32. Sakamoto A, Yamamoto M, Takahashi M, Ajiki K, Ota S, Murakami A, Mutou M, Imai K,
Maruta T, Yoshikawa H, Ishizaka N, Yamashita H, Hirata Y, Nagai R. A case of myasthenia gravis with cardiac fibrosis and easily provoked sustained ventricular tachycardia. J Cardiol Cases 2:41-44, 2010

33. Takahashi K, Komai K, Ishida C, Tagami A, Machiya T, Shima K. Progressive myelopathy with hyperintensity on T2-weighted spinal MRI. J Clin Neurosci 17:85, 155, 2010

34. Takahashi K. Isolated antiphospholipid syndrome of the central nervous system with positive lupus anticoagulant: two case reports. J Med Cases 1:108-110, 2010

35. Takahashi K. Systemic sclerosis with asymptomatic demyelination detected on brain MRI. Intern Med 49:1255-1256, 2010

36. Tsuda E, Imai T, Hozuki T, Yamauchi R, Saitoh M, Hisahara S, Yoshikawa H, Motomura M, Shimohama S. Correlation of bite force with excitation-contraction coupling time of the masseter in myasthenia gravis. Clin Neurophysiol 121:1051-1058, 2010

37. Wang J, Ono K, Dickstein D, Arrieta-Cruz I, Zhao W, Qian X, Lamparello A, Ferruzzi MG, Pavlides C, Ho L, Hof P, Teplow DB, Pasinetti GM. Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. Neurobiol Aging (In Press)

38. Wang J, Santa-Maria I, Ho L, Ksiezak-Reding H, Ono K, Teplow DB, Pasinetti GM. Inhibition of tau aggregation by grape derived polyphenols in a mouse model of Alzheimer’s disease. J Alzheimers Dis (In Press)

39. Willey JZ, Moon YP, Paik MC, Yoshita M, DeCarli CS, Sacco RL, Elkind MS, Wright CB. Lower prevalence of silent brain infarcts in the physically active: Northern Manhattan Study. Neurology (In Press)
 
Reviews


1. Hamaguchi T, Ono K, Yamada M. Curcumin and Alzeheimer’s disease. CNS Neurosci Ther 16:285-297, 2010

2. Ono K, Yamada M. Low-n oligomers as therapeutic targets of Alzheimer’s disease. J Neurochem (In Press)
 
 

Presentations (International meeting)

 
Invited lectures


1. Takamori M. Antibodies against calcium-release and -influx channels in myasthenia gravis and therapeutic strategy by FK506. BIT Life Sciences 2nd International Congress of Antibodies, Beijing, March 24-25, 2010

2. Yamada M. 132I-MIBG myocardial scintigraphy. NINDS: Biomarkers for Lewy Body Disease Conference, Washington, D.C., April 25-27, 2010

3. Yamada M, Hamaguchi T, Ono K, Hirohata M, Morinaga A, Ikeda T, Takasaki J, Murase A. The effects of phenolic compounds on Aβ aggregation and cerebral Aβ plaques and angiopathy. 2nd International CAA Conference : Cerebral Amyloid Angiopathy and Related Microangiopathies, Los Angeles, May 13-15, 2010

4. Yamada M, Nakamura Y, Takumi I. CJD Surveillance in Japan. European CJD Surveillance Network, Rotterdam, June 17-18, 2010

5. Yamada M. Prion diseases in Japan: dura mater graft-associated CJD and unique phenotypes of sporadic CJD and genetic prion diseases. Neuroscience Seminar at Univ. of Tübingen, Tübingen, September 7, 2010
 
Presentations


1. Atarashi R, Satoh K, Sano K, Fuse T, Yamanaka H, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamada M, Mizusawa H, Kitamoto T, McGlade A, Collins SJ, Shirabe S, Katamine S, Nishida N. Ultrasensitive human prion detection in cerebrospinal fluids by real-time quaking-induced conversion. PRION2010, Salzburg, September 8-11, 2010

2. Ishida C, Komai K, Yonezawa K, Sakajiri K, Nitta E, Kawashima A, Yamada M. An aged patient with spinocerebellar ataxia type 2: An autopsy case report with review of the literature. The 17th International Congress of Neuropathology, Salzburg, September 11-15, 2010

3. Komai K, Matsushita R, Kondo Y, Ishida N, Ishida C. Pharmacokinetics and tissue distribution of 3,4-diaminopyridine. XII International Congress on Neuromuscular Diseases (XIIth ICNMD), Naples, July 20, 2010

4. Maruta T, Yoshikawa H. Autoantibody to dihydropyridine receptor in myasthenia gravis. 14th International Congress of Immunology, Kobe, August 22-27, 2010

5. Morinaga A, Hasegawa K, Nomura R, Ookoshi T, Ozawa D, Goto Y, Yamada M, Naiki H. The Role of Interfaces and Agitation on the Fibril Formation of Amyloid β-Protein. Alzheimer’s Association International Conference on Alzheimer’s Disease 2010, Honolulu, July 10-15, 2010

6. Nanba E, Adachi K, Ishii K, Nakayama Y, Kohno Y, Yano M, Sato C, Arinami T, Sugie H, Goto Y, Sasaki T, Ohno K, Narita A, Fujii Y, Kashiwabara K, Haritani Y, Watanabe H, Segawa F, Nozaki I. Japanese Cases of Fragile-X-associated tremor/ataxia syndrome (FXTAS). 12th International fragile X conference, Detroit, July 21-25, 2010

7. Negami M, Maruta T, Kado H, Yoshikawa H. Sympathetic Skin Response and AA-interval spectral analysis to screen Lewy body disease. 29th International Congress of Clinical Neurophysiology, Kobe, October 28-November 1, 2010

8. Noto D, Takahashi K, Yamada M, Yamamura T, Miyake S. In vitro differentiation of lineage-negative bone marrow cells and monocyte into microglia-like cells. Neuroimmunology Kyoto Conference 2010, Kyoto, August 18-21, 2010

9. Noto D, Takahashi K, Yamamura T, Yamada M, Miyake S. In vitro differentiation of lineage-negative bone marrow cells and monocyte into microglia-like cells. The 10th International Congress of Neuroimmunology, Barcelona, October 26-30, 2010

10. Ohara M, SanjoN, Hizume M, Sakai K, Nozaki I, Hamaguchi T, NakamuraY, Kitamoto T, Shiga Y, Satoh K, Satoh T, Shirabe S, Yamada M, Tateishi J, Mizusawa H. Genetic prion diseases in Japan, an analysis based on the Japanese CJD surveillance, 1999-2009. PRION2010, Salzburg, September 8-11, 2010

11. Ono K, Teplow DB, Condron MM. Structure-neurotoxicity analysis of amyloid   β-protein oligomers. Alzheimer’s Association International Conference on Alzheimer’s Disease 2010, Honolulu, July 10-15, 2010

12. Sadakane A, Nakamura Y, Yamada M, Mizusawa H. Epidemiologic features of Creutzfeldt-Jakob disease(CJD) in Japan: results from 10-year surveillance.   The Joint Scientific Meeting of IEA Western Pacific Region and Japan Epidemiological Associaton, Saitama, January 9-10, 2010

13. Sakai K, Nozaki I, Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Sanjo N, Moriwaka F, Shiga Y, Kuroiwa Y,  Nishizawa M, Inuzuka T, Takeda M, Abe K, Murai H, Murayama S, Tateishi J, Shirabe S, Takumi I, Harada M, Yamada M. Human prion disease in Japan: a prospective surveillance from 1999. AOSPD2010, Sapporo, July 24-25, 2010

14. Sakai K, Nozaki I, Hamaguchi T, Noguchi-Shinohara M, NakamuraY, Sato T, Kitamoto T, Mizusawa H, Sanjo N, Moriwaka F, Shiga Y, Kuroiwa Y,  Nishizawa M, Inuzuka T, Takeda M, Abe K, Murai H, Murayama S, Tateishi J, Shirabe S, Takumi I, Harada M, Yamada M. Human prion diseases in Japan. PRION2010, Salzburg, September 8-11, 2010

15. Sakai K, Yamada M. Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra. The17th International Congress of Neuropathology, Salzburg, September 11-15, 2010

16. Takahashi K, Kato-Motozaki Y, Hirohata M, Tagami A, Ishida C, Komai K. Efficacy of ramatroban treatment for multiple sclerosis patients. The 10th International Congress of Neuroimmunology, Barcelona, October 26-30, 2010

17. Wang J, Santa-Maria I, Ho L, Ksiezak-Reding H, Ono K, Teplow DB, Pasinetti GM. Grape derived polyphenols attenuate tau neuropathology in the tmht mouse model of Alzheimer’s disease. Neuroscience Nanosymposium 2010, San Diego, November 13-17, 2010

18. Yamada M, Ono K, Hamaguchi T, Hirohata M, Morinaga A, Ikeda T, Takasaki J, Murase A, Naiki H, David B. Teplow. Phenolic compounds inhibit Aβ aggregation and prevent Alzheimer pathology in in vitro and in vivo models. Alzheimer’s Association International Conference on Alzheimer’s Disease 2010, Honolulu, July 10-15, 2010

19. Yoshikawa H, Adachi Y. Total health promotion by health service center in university setting. American College Health Association 2010 Annual Meeting Philadelphia, June 1-5, 2010
 
TOPへ戻る